Trials / Completed
CompletedNCT00475319
Late Phase 2 Study of OPC-12759 Ophthalmic Suspension
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 308 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the dose-response of OPC-12759 suspension in dry eye patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | placebo | comparison of different dosages of drug |
| DRUG | 1% OPC-12759 ophthalmic suspension | comparison of different dosages of drug |
| DRUG | 2% OPC-12759 ophthalmic suspension | comparison of different dosages of drug |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2008-03-01
- Completion
- 2008-06-01
- First posted
- 2007-05-21
- Last updated
- 2013-06-13
- Results posted
- 2013-06-05
Locations
6 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00475319. Inclusion in this directory is not an endorsement.